Skip to main content
Premium Trial:

Request an Annual Quote

Tetracore Gets CE-IVD Mark for RT-PCR Thermocycler

NEW YORK (GenomeWeb) – Tetracore announced today that it has received CE-IVD marking for its T-Cor 8 portable real-time PCR thermocycler.

The T-Cor 8 is a point-of-care diagnostic system that enables real-time molecular testing in hospitals, clinics, physician offices, and the field, according to the company. It can be plugged in or run on a built-in battery, is cloud-ready and networkable, and allows for multiple protocols simultaneously. It also features eight independently programmable wells, an integrated barcode scanner, and report downloading via network or USB drive.

With the CE-IVD marking, the system is now approved for sale throughout the European Economic Area.

Tetracore is currently developing a variety of tests for the T-Cor 8, including panels for respiratory viruses, hospital-acquired infections, and gastrointestinal infectious disease. In early 2015, the company won a National Institutes of Health grant to develop an assay that detects and distinguishes dengue and chikungunya viruses.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.